We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,142 results
  1. Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis

    Background

    The number of patients treated with extracorporeal membrane oxygenation (ECMO) devices is increasing. Anticoagulation therapy is crucial to...

    René M’Pembele, Sebastian Roth, ... Ragnar Huhn in Thrombosis Journal
    Article Open access 28 July 2022
  2. Direct Oral Anticoagulants: An Update on Monitoring and Antidotes for the Perioperative Physician

    Purpose of Review

    The purpose of this review is to update the clinician on assessing and reversing the effects of direct oral anticoagulants (DOACs)...

    Antasia Giebler, Roman Sniecinski in Current Anesthesiology Reports
    Article 27 April 2024
  3. Evaluation of direct thrombin inhibitors during a critical heparin shortage

    A recent heparin shortage related to an outbreak of African Swine Flu in China led to substantial increase in the use of direct thrombin inhibitors...

    Christine S. Ji, Russel J. Roberts, ... Rachel P. Rosovsky in Journal of Thrombosis and Thrombolysis
    Article 05 January 2021
  4. Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme

    Rivaroxaban is a direct factor Xa inhibitor, recently implemented as a favorable alternative to warfarin in anticoagulation therapy. Rivaroxaban...

    Justin J. W. Garabon, Michael B. Boffa in Journal of Thrombosis and Thrombolysis
    Article 13 June 2023
  5. Ultrasound (US)-guided percutaneous thrombin injection for stoma-site bleeding after PEG tube insertion: a case series and review of the literature

    Background

    Post-gastrostomy bleeding sequelae are acknowledged, with reported approaches focusing on conservative measures or surgical repair....

    Aws Alfahad, Rawan Alhalabi in CVIR Endovascular
    Article Open access 20 February 2024
  6. Integrative analysis of HASMCs gene expression profile revealed the role of thrombin in the pathogenesis of atherosclerosis

    We explored the effect of thrombin on human aortic smooth muscle cells (HASMCs) and further analyzed its role in the pathogenesis of atherosclerosis...

    Yichen Zhang, Lin Sun, ... Qingbo Zhou in BMC Cardiovascular Disorders
    Article Open access 12 April 2023
  7. Do Oral Factor Xa Inhibitors have a Role in Patients with Mechanical Heart Valves?

    Mechanical heart valves (MHVs) replacement is recommended for younger patients with valvular heart disease because of the durability of the...

    Article 23 July 2022
  8. Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives

    Purpose of the Review

    Thrombotic risk assessment in antiphospholipid positive (aPL +) subjects is a major challenge, and the study of in vitro...

    Thomas Foret, Virginie Dufrost, ... Denis Wahl in Current Rheumatology Reports
    Article 19 February 2024
  9. Calibrated automated thrombogram II: removing barriers for thrombin generation measurements

    Background

    Thrombin generation (TG) assessed by Calibrated Automated Thrombogram (CAT-I) reflects the overall capacity of plasma to generate thrombin,...

    P. L. A. Giesen, A. J. W. Gulpen, ... H. M. H. Spronk in Thrombosis Journal
    Article Open access 28 August 2021
  10. Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma

    The issue of how to identify newly diagnosed multiple myeloma (NDMM) patients requiring thromboprophylaxis remains unsolved. Several changes in...

    Diego Velasco-Rodríguez, Inés Martínez-Alfonzo, ... Pilar Llamas-Sillero in Journal of Thrombosis and Thrombolysis
    Article 11 January 2023
  11. Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC–MS/MS

    Since direct oral anticoagulants (DOAC) are administered frequently to an elderly, co-morbid population, medical emergencies including trauma, acute...

    Lea Brückner, Jan Beyer-Westendorf, ... Jörg Pietsch in Journal of Thrombosis and Thrombolysis
    Article Open access 11 November 2021
  12. Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background

    Background

    The current study aims to identify the relationships between coagulation factors and plasma thrombin generation in a large population-based...

    Pauline C. S. van Paridon, Marina Panova-Noeva, ... Henri M. H. Spronk in Thrombosis Journal
    Article Open access 08 June 2022
  13. Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy

    Anticoagulation therapy has undergone significant evolution, marked by the emergence of direct oral anticoagulants with distinct advantages. Despite...

    João Presume, Jorge Ferreira, Regina Ribeiras in Cardiology and Therapy
    Article Open access 02 February 2024
  14. When and How to Use Reversal Agents for Direct Oral Anticoagulants?

    Purpose of Review

    Our objective is to describe currently available reversal agents for direct oral anticoagulants (DOACs), their target population,...

    Antonio Gómez-Outes, Mª Luisa Suárez-Gea, Ramón Lecumberri in Current Cardiology Reports
    Article 28 March 2023
  15. Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections

    Human factor Xa (FXa) is a serine protease of the common coagulation pathway. FXa is known to activate prothrombin to thrombin, which eventually...

    Article 12 September 2020
  16. Thrombin Generation in Trauma Patients: How Do we Navigate Through Scylla and Charybdis?

    Purpose of Review

    Coagulopathy is a complex pathological condition manifested through the insufficient or excessive tendency to form blood thrombi,...

    Alexander Y. Mitrophanov, Kofi Vandyck, Kenichi A. Tanaka in Current Anesthesiology Reports
    Article Open access 24 January 2022
  17. Modified thromboelastometric tests provide improved sensitivity and specificity to direct oral anticoagulants compared to standard thromboelastometric tests in-vitro

    Background

    The detection of direct oral anticoagulants (DOACs) is still challenging but important in emergency patients. We recently demonstrated that...

    Philipp Groene, Jennifer Butte, ... Simon T. Schäfer in Thrombosis Journal
    Article Open access 21 July 2022
  18. Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15

    G-protein coupled receptor 15 (GPR15) is expressed on T-cells. We previously reported knockout of GPR15 increased acute graft- versus -host disease (G v H...

    Cong Liu, Qiu Lan, ... Bin Pan in Leukemia
    Article 08 March 2024
  19. Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis

    Introduction

    Guidelines have endorsed non-vitamin K antagonist oral anticoagulants (NOACs), consisting of factor Xa inhibitors (xabans) and direct...

    Dae Yong Park, Seokyung An, ... Aviral Vij in BMC Cardiovascular Disorders
    Article Open access 22 February 2023
  20. Factor XI Inhibitors: perspectives in primary and secondary prevention of ischemic stroke

    Stroke is one of the most common causes of mortality and disability worldwide. Antithrombotic therapy represents the mainstay in primary and...

    Domenico Prisco, Maria Canfora, ... Alessandra Bettiol in Internal and Emergency Medicine
    Article Open access 14 May 2024
Did you find what you were looking for? Share feedback.